Banque Pictet & Cie’s Nu Skin NUS Stock Holding History

Banque Pictet & Cie’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3,335	Closed	-$461K	–	445
2013 Q4	$461K	Buy	+3,335	New	+$393K	0.01%	264

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ESG

Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Banque Pictet & Cie's NUS Position: Q1 2014 in Review

Banque Pictet & Cie sold out of Nu Skin (NUS) in Q1 2014, closing a stake of 3,335 shares — an estimated $461K sold.

Banque Pictet & Cie first reported a position in NUS in Q4 2013 and held it in 1 quarter. The position peaked at $461K in Q4 2013. 289 funds tracked by Wall St. Rank hold NUS as of Q1 2014.

Banque Pictet & Cie reported no remaining Nu Skin position as of Q1 2014 after selling out during the quarter.
Banque Pictet & Cie sold 3,335 Nu Skin shares in Q1 2014, an estimated $461K.
Banque Pictet & Cie first reported a position in Nu Skin in Q4 2013 and held it in 1 quarter.
Banque Pictet & Cie's Nu Skin position peaked at $461K in Q4 2013.
289 funds tracked by Wall St. Rank held Nu Skin as of Q1 2014.

Based on Banque Pictet & Cie's 13F filing for Q1 2014, filed 9 May 2014.